Skip to main content

(Approval lapsed) FLUMAZENIL 0.5mg/5mL Injection, USP 5mL vial

Section 19A approved medicine
(Approval lapsed) FLUMAZENIL 0.5mg/5mL Injection, USP 5mL vial
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
DBL FLUMAZENIL INJECTION flumazenil 0.5mg/5mL solution for injection ampoule - ARTG 121098
Flumazenil APOTEX flumazenil 0.5 mg/ 5 mL solution for injection ampoule - ARTG 236672
Indication(s)

For use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). Hospitalised patients are patients who are admitted to hospital, under inpatient care and under continued professional observation while under the influence of flumazenil. Not to be used in outpatients or short stay patients. Not to be used as a diagnostic.

Help us improve the Therapeutic Goods Administration site